Kiniksa Pharmaceuticals International, plc
Public company- Headquarters
- LONDON
- Ticker
- KNSA
- CIK
- 0001730430
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| COORoss Moat | Oct 22, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- TEVA PHARMACEUTICAL INDUSTRIES LTD
WARN notice: Fairfield, NJ
- NOVARTIS AG
WARN notice: East Hanover, NJ
- IMMUNIC, INC.
member of the Board of Directors departs: Duane Nash
- Executive appointment
COO appointed: Ross Moat
Ross Moat was named President and Chief Operating Officer of Kiniksa Pharmaceuticals International, plc, effective October 17, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 22, 2026Role: President and Chief Operating Officer
Only one public record so far. We add events as soon as a new filing lands; watch Kiniksa Pharmaceuticals International, plc to get them in your digest.
Last verified Nov 8, 2026